A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

Behnke accused CVS Caremark of having since 2010 caused health insurers, such as Aetna, to submit inflated claims to the ...

From late penalties to premium reimbursements, here’s what every retired fed should understand about enrolling in Medicare ...

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that could ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

Lawmakers must look past the bureaucratic squabbles and politics to focus on the patients that these reforms will help. These savings will go a long way for Medicare patients, including seniors ...